Effects of neuroprotector cortexin on the dynamics of neuroendocrine system parameters in patients with organic emotionally labile (asthenic) disorders

Bull Exp Biol Med. 2013 May;155(1):75-7. doi: 10.1007/s10517-013-2083-7.

Abstract

Addition of neuroprotector Cortexin to standard drug therapy of patients with organic emotionally labile (asthenic) disorders had a great influence on the neuroendocrine system and neurosteroid content: normalization of blood concentration of cortisol, dehydroepiandrosterone sulphate, and thyroid hormones was observed. Clinical improvement was associated with the recovery of organism homeostatic systems.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Affective Symptoms / drug therapy*
  • Asthenia / drug therapy*
  • Dehydroepiandrosterone Sulfate / blood
  • Female
  • Humans
  • Hydrocortisone / blood
  • Intercellular Signaling Peptides and Proteins
  • Male
  • Mood Disorders / drug therapy*
  • Neuroprotective Agents / therapeutic use*
  • Neurosecretory Systems / drug effects
  • Peptides / therapeutic use*
  • Thyroid Hormones / blood
  • Treatment Outcome

Substances

  • Intercellular Signaling Peptides and Proteins
  • Neuroprotective Agents
  • Peptides
  • Thyroid Hormones
  • Dehydroepiandrosterone Sulfate
  • cortexin
  • Hydrocortisone